NRGene Technologies Ltd (TLV:NRGN)
228.50
-4.50 (-1.93%)
Jan 30, 2026, 1:44 PM IDT
NRGene Technologies Company Description
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.
It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing genetic information.
The company also offers Supree semi-dried cherry tomatoes; clubroot-resistant canola; and black soldier fly as an alternative to animal-based protein.
Its technology portfolio includes DeNovoMAGIC, a de novo assembly solution that assembles genomes. The company was incorporated in 2009 and is based in Ness Ziona, Israel.
NRGene Technologies Ltd
| Country | Israel |
| Founded | 2009 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 29 |
| CEO | Gil Ronen |
Contact Details
Address: 2 Ilan Ramon Street Ness Ziona Israel | |
| Phone | 972 7 222 03750 |
| Website | nrgene.com |
Stock Details
| Ticker Symbol | NRGN |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011720716 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gil Ronen Ph.D. | Co-Founder, Chief Executive Officer and Director |
| Ron Avraham | Chief Financial Officer |
| Dr. Kobi Baruch Ph.D. | Chief Technology Officer |